rs315951

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_173842.3(IL1RN):​c.*138C>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.31 in 787,330 control chromosomes in the GnomAD database, including 42,486 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.34 ( 9445 hom., cov: 33)
Exomes 𝑓: 0.30 ( 33041 hom. )

Consequence

IL1RN
NM_173842.3 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.610

Publications

52 publications found
Variant links:
Genes affected
IL1RN (HGNC:6000): (interleukin 1 receptor antagonist) The protein encoded by this gene is a member of the interleukin 1 cytokine family. This protein inhibits the activities of interleukin 1, alpha (IL1A) and interleukin 1, beta (IL1B), and modulates a variety of interleukin 1 related immune and inflammatory responses, particularly in the acute phase of infection and inflammation. This gene and five other closely related cytokine genes form a gene cluster spanning approximately 400 kb on chromosome 2. A polymorphism of this gene is reported to be associated with increased risk of osteoporotic fractures and gastric cancer. Several alternatively spliced transcript variants encoding distinct isoforms have been reported. [provided by RefSeq, Aug 2020]
IL1RN Gene-Disease associations (from GenCC):
  • sterile multifocal osteomyelitis with periostitis and pustulosis
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 2-113133009-C-G is Benign according to our data. Variant chr2-113133009-C-G is described in ClinVar as Benign. ClinVar VariationId is 330832.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.59 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IL1RNNM_173842.3 linkc.*138C>G 3_prime_UTR_variant Exon 4 of 4 ENST00000409930.4 NP_776214.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IL1RNENST00000409930.4 linkc.*138C>G 3_prime_UTR_variant Exon 4 of 4 1 NM_173842.3 ENSP00000387173.3

Frequencies

GnomAD3 genomes
AF:
0.337
AC:
51270
AN:
152048
Hom.:
9431
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.424
Gnomad AMI
AF:
0.336
Gnomad AMR
AF:
0.235
Gnomad ASJ
AF:
0.206
Gnomad EAS
AF:
0.608
Gnomad SAS
AF:
0.147
Gnomad FIN
AF:
0.417
Gnomad MID
AF:
0.250
Gnomad NFE
AF:
0.297
Gnomad OTH
AF:
0.282
GnomAD4 exome
AF:
0.304
AC:
193077
AN:
635164
Hom.:
33041
Cov.:
8
AF XY:
0.295
AC XY:
100465
AN XY:
340110
show subpopulations
African (AFR)
AF:
0.426
AC:
7288
AN:
17116
American (AMR)
AF:
0.239
AC:
8368
AN:
35034
Ashkenazi Jewish (ASJ)
AF:
0.209
AC:
4230
AN:
20276
East Asian (EAS)
AF:
0.644
AC:
21027
AN:
32670
South Asian (SAS)
AF:
0.145
AC:
9435
AN:
65018
European-Finnish (FIN)
AF:
0.419
AC:
18184
AN:
43356
Middle Eastern (MID)
AF:
0.206
AC:
569
AN:
2764
European-Non Finnish (NFE)
AF:
0.295
AC:
113977
AN:
385926
Other (OTH)
AF:
0.303
AC:
9999
AN:
33004
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
6794
13588
20382
27176
33970
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1398
2796
4194
5592
6990
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.337
AC:
51306
AN:
152166
Hom.:
9445
Cov.:
33
AF XY:
0.338
AC XY:
25155
AN XY:
74392
show subpopulations
African (AFR)
AF:
0.424
AC:
17603
AN:
41524
American (AMR)
AF:
0.235
AC:
3600
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.206
AC:
714
AN:
3472
East Asian (EAS)
AF:
0.607
AC:
3136
AN:
5164
South Asian (SAS)
AF:
0.145
AC:
698
AN:
4822
European-Finnish (FIN)
AF:
0.417
AC:
4413
AN:
10592
Middle Eastern (MID)
AF:
0.238
AC:
70
AN:
294
European-Non Finnish (NFE)
AF:
0.297
AC:
20174
AN:
67984
Other (OTH)
AF:
0.281
AC:
592
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1736
3473
5209
6946
8682
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
480
960
1440
1920
2400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.331
Hom.:
1285
Bravo
AF:
0.332
Asia WGS
AF:
0.355
AC:
1234
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
Nov 12, 2023
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 42% of patients studied by a panel of primary immunodeficiencies. Number of patients: 40. Only high quality variants are reported. -

Sterile multifocal osteomyelitis with periostitis and pustulosis Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
7.0
DANN
Benign
0.51
PhyloP100
0.61
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs315951; hg19: chr2-113890586; API